Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Corr L. A., Oliver M. F. The low fat/low cholesterol diet is ineffective. Eur Heart J. 1997 Jan;18(1):18–22. doi: 10.1093/oxfordjournals.eurheartj.a015111. [DOI] [PubMed] [Google Scholar]
- Jukema J. W., Bruschke A. V., van Boven A. J., Reiber J. H., Bal E. T., Zwinderman A. H., Jansen H., Boerma G. J., van Rappard F. M., Lie K. I. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation. 1995 May 15;91(10):2528–2540. doi: 10.1161/01.cir.91.10.2528. [DOI] [PubMed] [Google Scholar]
- Sacks F. M., Pfeffer M. A., Moye L. A., Rouleau J. L., Rutherford J. D., Cole T. G., Brown L., Warnica J. W., Arnold J. M., Wun C. C. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996 Oct 3;335(14):1001–1009. doi: 10.1056/NEJM199610033351401. [DOI] [PubMed] [Google Scholar]
- Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]
- Treasure C. B., Klein J. L., Weintraub W. S., Talley J. D., Stillabower M. E., Kosinski A. S., Zhang J., Boccuzzi S. J., Cedarholm J. C., Alexander R. W. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995 Feb 23;332(8):481–487. doi: 10.1056/NEJM199502233320801. [DOI] [PubMed] [Google Scholar]
- Ul Haq I., Ramsay L. E., Pickin D. M., Yeo W. W., Jackson P. R., Payne J. N. Lipid-lowering for prevention of coronary heart disease: what policy now? Clin Sci (Lond) 1996 Oct;91(4):399–413. doi: 10.1042/cs0910399. [DOI] [PubMed] [Google Scholar]
- Vos J., de Feyter P. J., Simoons M. L., Tijssen J. G., Deckers J. W. Retardation and arrest of progression or regression of coronary artery disease: a review. Prog Cardiovasc Dis. 1993 May-Jun;35(6):435–454. doi: 10.1016/0033-0620(93)90028-c. [DOI] [PubMed] [Google Scholar]
- Waters D., Higginson L., Gladstone P., Kimball B., Le May M., Boccuzzi S. J., Lespérance J. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. Circulation. 1994 Mar;89(3):959–968. doi: 10.1161/01.cir.89.3.959. [DOI] [PubMed] [Google Scholar]